Join
Live feed
·
INSIDERFilingvia Quantisnow
Biogen Inc. logo

Director Pangalos Menelas N converted options into 2,370 shares and was granted 1,505 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BIIB· Biogen Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIIB (Biogen Inc.) and more on Quantisnow.